Physician profile
Clark E Boccone
NPI 1285832287
$8,333.79
in general payments reported to CMS, 2019-2025
29 companies · $639 in 2025
The $639 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $55.40 · 2021: $142 · 2022: $225 · 2023: $497 · 2024: $6,450 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,152 · Travel and Lodging: $1,425 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,152.45 |
| Travel and Lodging | $1,424.61 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,922.47 | 2024 | |
| Sumitomo Pharma America, INC. | $434.22 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $240.58 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $226.68 | 2019-2023 | Orilissa |
| Coopersurgical, INC. | $184.23 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Novo Nordisk INC | $167.75 | 2019-2024 | Wegovy |
| Biogen, INC. | $150.68 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $115.72 | 2020-2025 | Slynd |
| Axonics, INC. | $111.85 | 2023-2024 | Axonics, Bulkamid |
| Minerva Surgical, INC | $98.55 | 2023-2025 | |
| Daiichi Sankyo INC. | $85.58 | 2019-2022 | |
| Millicent US INC | $76.88 | 2024-2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $70.42 | 2022-2025 | |
| Hologic Sales and Service, LLC | $58.75 | 2019-2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Agile Therapeutics, INC. | $56.44 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $53.74 | 2021-2022 | |
| Therapeuticsmd, INC. | $51.71 | 2020-2022 | |
| Organon LLC | $43.02 | 2023-2025 | Nexplanon |
| Duchesnay USA Incorporated | $23.45 | 2019 | |
| Medtronic, INC. | $21.46 | 2021 | |
| Lilly USA, LLC | $20.67 | 2024 | Jardiance, Zepbound |
| Pacira Pharmaceuticals Incorporated | $19.82 | 2022 | |
| Exact Sciences Corporation | $18.54 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $14.88 | 2023 | Balcoltra |
| Meditrina | $14.53 | 2023 | |
| Coloplast Corp | $14.34 | 2023 | Altis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.47 | 2019 | |
| Allergan, INC. | $12.36 | 2019 | |
| Asensus Surgical, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Boccone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.